Research Article
Indices of Paraoxonase and Oxidative Status Do Not Enhance the Prediction of Subclinical Cardiovascular Disease in Mixed-Ancestry South Africans
Table 2
Robust correlation of CIMT with PON and antioxidant status.
| | Correlates | Overall | No diabetes | Diabetes | value |
| | PON1 | −0.09 (−0.17 to 0.00) | −0.04 (−0.14 to 0.07) | −0.01 (−0.17 to 0.16) | 0.74 | | PONase | −0.17 (−0.25 to −0.08) | −0.11 (−0.21 to 0) | 0.04 (−0.13 to 0.20) | 0.15 | | AREase | −0.24 (−0.32 to −0.15) | −0.20 (−0.30 to −0.09) | −0.05 (−0.21 to 0.12) | 0.13 | | FRAP | −0.17 (−0.26 to −0.09) | −0.12 (−0.22 to −0.02) | 0.03 (−0.13 to 0.20) | 0.12 | | TEAC | −0.22 (−0.30 to −0.13) | −0.16 (−0.26 to −0.06) | 0.04 (−0.12 to 0.21) | 0.04 | | Ox-LDL | 0.25 (0.17 to 0.34) | 0.21 (0.10 to 0.30) | −0.03 (−0.20 to 0.13) | 0.02 | | TBARS | 0.26 (0.17 to 0.34) | 0.19 (0.09 to 0.29) | −0.01 (−0.17 to 0.16) | 0.04 |
|
|
Paraoxonase 1; PONase: paraoxonase; AREase: arylesterase; FRAP: ferric reducing ability of plasma; TEAC: trolox equivalent antioxidant capacity; Ox-LDL: oxidized LDL; TBARS: thiobarbituric acid reactive substances.
|
